HOUSTON, Jan. 6, 2025
/PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company")
(NASDAQ: NUTX), a physician-led, integrated healthcare delivery
system comprised of 24 state-of-the-art micro-hospitals in 11
states and primary care-centric, risk-bearing physician networks,
today announced that it will be presenting at the industry's
largest healthcare investment symposium— the
43rd Annual J.P. Morgan Healthcare Conference. This
event will take place from January
13th to 16th in San Francisco, California.
Nutex Health Presentation Details:
Date: Thursday, January 16, 2025
Time: 10:30 AM – 11:10 AM PST
Venue: Elizabethan B Conference Room at the Westin St. Francis
Hotel in San Francisco
In addition to the formal presentation, company management will
be available to participate in one-on-one meetings with qualified
members of the investor community who are registered to attend the
conference.
About Nutex Health Inc.
Headquartered in Houston, Texas and founded in 2011,
Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and
operations company with two divisions: a Hospital Division and a
Population Health Management Division.
The Hospital Division owns, develops and operates innovative
health care centers including micro-hospitals, specialty
hospitals, and hospital outpatient departments (HOPDs). This
division owns and operates 24 facilities in 11 states.
The Population Health Management division owns and operates
provider networks such as Independent Physician Associations
(IPAs).
Forward-Looking Statements
Certain statements and information included in this press
release constitute "forward-looking statements" within the meaning
of the Private Securities Litigation Act of 1995. When used in this
press release, the words or phrases "will", "will likely result,"
"expected to," "will continue," "anticipated," "estimate,"
"projected," "intend," "goal," or similar expressions are intended
to identify "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements
are subject to certain risks, known and unknown, and uncertainties,
many of which are beyond the control of the Company. Such
uncertainties and risks include, but are not limited to, our
ability to successfully execute our growth strategy, changes in
laws or regulations, including the interim final and final rules
implemented under the No Surprises Act , economic conditions,
dependence on management, dilution to stockholders, lack of
capital, the effects of rapid growth upon the Company and the
ability of management to effectively respond to the growth and
demand for products and services of the Company, newly developing
technologies, the Company's ability to compete, conflicts of
interest in related party transactions, regulatory matters,
protection of technology, lack of industry standards, the effects
of competition and the ability of the Company to obtain future
financing. An extensive list of factors that can affect future
results are discussed in the Annual Report on Form 10-K for the
year ended December 31, 2023 and in
the Quarterly Reports on Form 10-Q for the periods ended
March 31, 2024, June 30, 2024 and September 31, 2024under the heading "Risk
Factors" in Part I, Item IA thereof, and other documents filed from
time to time with the Securities and Exchange Commission. Such
factors could materially adversely affect the Company's financial
performance and could cause the Company's actual results for future
periods to differ materially from any opinions or statements
expressed within this press release.
View original
content:https://www.prnewswire.com/news-releases/nutex-health-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302342645.html
SOURCE Nutex Health, Inc.